Bilateral Proliferative Retinopathy as the Initial Presentation of Chronic Myeloid Leukemia

被引：14

作者：

Macedo, Mafalda S. F. ^{[1
]}

Figueiredo, Ana R. M. ^{[1
]}

Ferreira, Natalia N. ^{[1
]}

Barbosa, Irene M. A. ^{[1
]}

Furtado, Maria Joao F. B. S. ^{[1
]}

Correia, Nuno F. C. B. A. ^{[1
]}

Gomes, Miguel P. ^{[1
]}

Lume, Miguel R. B. ^{[1
]}

Meneres, Maria Joao S. ^{[1
]}

Santos, Marinho M. N. ^{[1
]}

Meireles, M. Angelina C. S. ^{[1
]}

机构：

[1] Hosp Santo Antonio, Ctr Hosp Porto, Dept Ophthalmol, Oporto, Portugal

来源：

MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY | 2013年 / 20卷 / 04期

关键词：

Chronic Myeloid Leukemia; Hyperviscosity Syndrome; Proliferative Retinopathy;

D O I：

10.4103/0974-9233.120016

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The authors report a rare case of a 48-year-old male with chronic myeloid leukemia (CML) who initially presented with a bilateral proliferative retinopathy. The patient complained of recent visual loss and floaters in both eyes (BE). Ophthalmologic evaluation revealed a best corrected visual acuity (BCVA) of 20/50 in the right eye and 20/200 in the left eye (LE). Fundoscopy showed the presence of bilateral peripheral capillary dropout with multiple retinal sea fan neovascularisations, which were confirmed on fluorescein angiography. Full blood count revealed hyperleukocytosis, thrombocytosis, anemia, and hyperuricemia. Bone marrow aspiration and biopsy showed the reciprocal chromosomal translocation t (9;22), diagnostic of CML. The patient was started on hydroxyurea, allopurinol and imatinib mesylate. He received bilateral panretinal laser photocoagulation and a vitrectomy was performed in the LE. The patient has been in complete hematologic, cytogenetic, and major molecular remission while on imatinib and his BCVA is 20/25 in BE.

引用

页码：353 / 356

页数：4

共 12 条

[1] Quintas-Cardama A., Cortes J., Molecular biology of bcr-abl1-positive chronic myeloid leukemia, Blood, 113, pp. 1619-1630, (2009)
[2] Cancer Statistics Review 1975-2009 (Vintage 2009 Populations)
[3] Huynh T.H., Johnson M.W., Hackel R.E., Bilateral proliferative retinopathy in chronic myelogenous leukemia, Retina, 27, pp. 124-125, (2007)
[4] Mahneke A., Videbaek A., On changes in the optic fundus in leukaemia aetiology, diagnostic and prognostic role, Acta Ophthalmol (Copenh), 42, pp. 201-210, (1964)
[5] Mandava N., Costakos D., Bartlett H.M., Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy, Arch Ophthalmol, 123, pp. 576-577, (2005)
[6] Nobacht S., Vandoninck K.F., Deutman A.F., Klevering B.J., Peripheral retinal nonperfusion associated with chronic myeloid leukemia, Am J. Ophthalmol, 135, pp. 404-406, (2003)
[7] Cortes J., Natural history and staging of chronic myelogenous leukemia, Hematol Oncol Clin North Am, 18, pp. 569-584, (2004)
[8] Baccarani M., Cortes J., Pane F., Niederwieser D., Saglio G., Apperley J., Et al., Chronic myeloid leukemia: An update of concepts and management recommendations of European LeukemiaNet, J. Clin Oncol, 27, pp. 6041-6051, (2009)
[9] Gambacorti-Passerini C., Antolini L., Mahon F.X., Guilhot F., Deininger M., Fava C., Et al., Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib, J. Natl Cancer Inst, 103, pp. 553-561, (2011)
[10] Jackson N., Reddy S.C., Hishamuddin M., Low H.C., Retinal findings in adult leukaemia: Correlation with leukocytosis, Clin Lab Haematol, 18, pp. 105-109, (1996)

← 1 2 →